Picture of OKYO Pharma logo

OKYO OKYO Pharma Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for OKYO Pharma, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments0.4810.194.992.063.28
Net Total Accounts Receivable
Net Total Receivables0.0850.2630.0550.6720.794
Prepaid Expenses
Total Current Assets0.5820.4585.063.274.21
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.0010.0250.0760.0040.006
Total Assets0.5830.4835.143.274.21
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.3270.5751.241.035.88
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities0.3270.5961.281.035.88
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity0.255-0.1133.852.24-1.66
Total Liabilities & Shareholders' Equity0.5830.4835.143.274.21
Total Common Shares Outstanding